Crossmark

The development of an effective synthetic route of lesinurad (RDEA594)

Crossref DOI link: https://doi.org/10.1186/s13065-017-0316-y

Published Online: 2017-09-05

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Meng, Qing

Zhao, Tong

Kang, Dongwei

Huang, Boshi

Zhan, Peng

Liu, Xinyong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81273354, 81573347, 81420108027)

Key research and development plan of Shandong Province (No. 2017CXGC1401)
License Information

Text and Data Mining valid from 2017-09-05
More Information

Article History

Received: 14 February 2017

Accepted: 29 August 2017

First Online: 5 September 2017